Effects of shRNA-silenced livin and survivin on lung cancer cell proliferation and apoptosis. 2014

Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
Department of Respiratory Medicine, the First Affiliated Hospital of Xinxiang Medical University, Weihui, P.R., China.

OBJECTIVE To evaluate the effects of short hairpin RNA (shRNA)-mediated silencing of livin and survivin on the proliferation and apoptosis of A549 lung cancer cells. METHODS We designed and constructed the eukaryotic expression vectors pSilencer-livin and pSilencer-survivin which contain the Livin and Survivin genes, respectively, and transfected them into liposome-combined lung cancer A549 cells. The cells were then divided into the blank control, plasmid control, Livin, Survivin, and co-transfected groups. Real-time quantitative PCR (qRT-PCR) and Western blot assay were used to determine the mRNA and protein expression levels of Livin and Survivin. The MTT assay was used to evaluate the changes in cell proliferation. The TUNEL assay was used to evaluate the apoptotic rate. RESULTS The shRNA eukaryotic expression vectors of Livin and Survivin were successfully constructed. The mRNA and protein expression of Livin and Survivin were significantly lower in the co-transfected group than in the control groups (p<0.05) . At 48, 60, and 72 hrs after transfection, the cell growth inhibition rate was significantly higher in the co-transfected group than in the single- transfected group (p<0.05) . At 48 hrs after transfection, the apoptotic rate significantly increased (p<0.05) . CONCLUSIONS Co-silencing of Livin and Survivin can effectively inhibit the cell proliferation and apoptosis of lung cancer cells.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077022 Survivin An apoptosis inhibitory protein that contains a single baculoviral IAP repeat (BIR) domain. It associates with MICROTUBULES and functions to regulate cell proliferation as a component of the chromosome passage protein complex (CPC), performing essential roles for localization of the complex, chromosome alignment, segregation during MITOSIS and CYTOKINESIS, and assembly of the MITOTIC SPINDLE. It is expressed by fetal kidney and liver cells and highly expressed in ADENOCARCINOMA and high-grade LYMPHOMA. BIRC5 Protein,Baculoviral IAP Repeat-containing Protein 5,Baculoviral IAP Repeat containing Protein 5
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051034 Inhibitor of Apoptosis Proteins A conserved class of proteins that control APOPTOSIS in both VERTEBRATES and INVERTEBRATES. IAP proteins interact with and inhibit CASPASES, and they function as ANTI-APOPTOTIC PROTEINS. The protein class is defined by an approximately 80-amino acid motif called the baculoviral inhibitor of apoptosis repeat; some members have ubiquitin-protein ligase activity. BIRC2 Protein,Baculoviral IAP Repeat Containing Protein 2,Baculoviral IAP Repeat-Containing 2 Protein,Baculoviral Inhibitor Of Apoptosis Repeat Proteins,Cellular Inhibitor of Apoptosis 1 Protein,IAP Protein (Apoptosis),IAP Repeat Containing Proteins,IAP2 Protein,Inhibitor of Apoptosis 2 Protein,Inhibitor-Of-Apoptosis Protein,c-IAP1 Protein,cIAP1 Protein,Apoptosis Proteins Inhibitor,Baculoviral IAP Repeat Containing 2 Protein,Inhibitor Of Apoptosis Protein

Related Publications

Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
November 2017, Molecular medicine reports,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
June 2006, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
October 2012, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
December 2004, Lung cancer (Amsterdam, Netherlands),
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
January 2002, Oncology reports,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
January 2013, International journal of molecular sciences,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
January 2006, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
October 2011, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
January 2013, Asian Pacific journal of cancer prevention : APJCP,
Xin Zhao, and Yan Yuan, and Zhiqiang Zhang, and Xianjun Feng, and Jian Zhang, and Xiaomei Yuan, and Jinlan Li
November 2004, Zhonghua yi xue za zhi,
Copied contents to your clipboard!